Medical Imaging Corp. (MEDD) Research

Medical Imaging Corp. (MEDD), operating through its various subsidiaries across North America, provides a comprehensive array of diagnostic imaging solutions for a diverse clientele, including individual patients, healthcare facilities, workers' compensation organizations, and insurance carriers. The company also specializes in teleradiology, offering remote analysis and reporting for medical scans. Its robust service portfolio encompasses modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of the end of 2017, its physical operations included a standalone diagnostic imaging center in Pottsville, Pennsylvania, in addition to three diagnostic facilities located throughout Florida. Established in 2000 and headquartered in Las Vegas, Nevada, the enterprise adopted its current name, Medical Imaging Corp., in July 2014, having previously operated as Diagnostic Imaging International Corp.

Market snapshot

Symbol
MEDD
Price
$0.00
Day change
0.00%
Market cap
$31.9K
P/E ratio
-0.00x
52-week range
0.00001-0.0002
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Decision Diagnostics Corp. (DECN)
  • Endonovo Therapeutics, Inc. (ENDV)
  • Filament Health Corp. (FLHLF)
  • Integrative Health Technologies, Inc. (IHTI)
  • Itoco Inc. (ITMC)
  • Nutranomics, Inc. (NNRX)
  • Primemd Inc. (PRMD)
  • Response Genetics, Inc (RGDXQ)

Open Medical Imaging Corp. (MEDD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.